NASDAQ: INOInovio Pharmaceuticals Inc Earnings Dates, Reports, Calls
Inovio Pharmaceuticals earnings were -$87.8M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest INO earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$23.5M, up 19.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INO reported annual earnings of -$107.3M, with -20.6% growth.
INO earnings history
Current Revenue
$182.3k
Current Earnings
-$87.8M
Current Profit Margin
-48,131.4%
INO Return on Equity
Current Company
-158.3%
Current Industry
-10.1%
Current Market
30.7%
INO's Return on Equity (-158.3%)... subscribe to Premium to read more.
High Return on Equity Performance
INO undefined
Current Company
-93.4%
Current Industry
-0.2%
INO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when INO announces earnings.
INO undefined
Current Company
-240.23%
Current Industry
6.4%
INO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
INO vs Biotech Stocks
Inovio Pharmaceuticals Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.